Trial Profile
A trial to assess rosuvastatin, versus atorvastatin, for the prevention of contrast-induced nephropathy in patients with chronic kidney disease who are scheduled to receive elective percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Kidney disorders
- Focus Therapeutic Use
- 16 Sep 2015 New trial record